PubRank

Raymond E Boissy

Author PubWeight™ 27.89‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cellular defects in Chediak-Higashi syndrome correlate with the molecular genotype and clinical phenotype. J Invest Dermatol 2007 1.47
2 Hermansky-Pudlak syndrome: vesicle formation from yeast to man. Pigment Cell Res 2002 1.28
3 Melanocortin 1 receptor genotype: an important determinant of the damage response of melanocytes to ultraviolet radiation. FASEB J 2010 1.23
4 4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediated killing: relevance to vitiligo. J Invest Dermatol 2005 1.20
5 Melanocytes derived from patients with Hermansky-Pudlak Syndrome types 1, 2, and 3 have distinct defects in cargo trafficking. J Invest Dermatol 2005 1.18
6 Regulation of tyrosinase trafficking and processing by presenilins: partial loss of function by familial Alzheimer's disease mutation. Proc Natl Acad Sci U S A 2005 1.07
7 Improper trafficking of melanocyte-specific proteins in Hermansky-Pudlak syndrome type-5. J Invest Dermatol 2007 1.04
8 A novel cytokine pathway suppresses glial cell melanogenesis after injury to adult nerve. J Neurosci 2002 1.00
9 Mechanisms regulating skin pigmentation: the rise and fall of complexion coloration. Int J Mol Sci 2009 0.98
10 A role for tyrosinase-related protein 1 in 4-tert-butylphenol-induced toxicity in melanocytes: Implications for vitiligo. Am J Pathol 2006 0.95
11 Monobenzyl ether of hydroquinone and 4-tertiary butyl phenol activate markedly different physiological responses in melanocytes: relevance to skin depigmentation. J Invest Dermatol 2010 0.93
12 Functional analysis of keratinocytes in skin color using a human skin substitute model composed of cells derived from different skin pigmentation types. FASEB J 2007 0.90
13 Membranous complexes characteristic of melanocytes derived from patients with Hermansky-Pudlak syndrome type 1 are macroautophagosomal entities of the lysosomal compartment. Pigment Cell Res 2005 0.90
14 Melanoma-associated antigen expression in lymphangioleiomyomatosis renders tumor cells susceptible to cytotoxic T cells. Am J Pathol 2009 0.88
15 Mechanistic effects of long-term ultraviolet B irradiation induce epidermal and dermal changes in human skin xenografts. Am J Pathol 2009 0.88
16 Association of the Hermansky-Pudlak syndrome type-3 protein with clathrin. BMC Cell Biol 2005 0.87
17 Production of the soluble form of KIT, s-KIT, abolishes stem cell factor-induced melanogenesis in human melanocytes. J Invest Dermatol 2008 0.87
18 Nipple connective tissue and its development: insights from the K14-PTHrP mouse. Mech Dev 2002 0.86
19 Cyclic voltammetric, fluorescence and biological analysis of purified aeruginosin A, a secreted red pigment of Pseudomonas aeruginosa PAO1. Microbiology 2013 0.83
20 Positioning ganglioside D3 as an immunotherapeutic target in lymphangioleiomyomatosis. Am J Pathol 2013 0.82
21 Comparative efficacy and safety of deoxyarbutin, a new tyrosinase-inhibiting agent. J Cosmet Sci 2006 0.82
22 Report of a novel OCA2 gene mutation and an investigation of OCA2 variants on melanoma risk in a familial melanoma pedigree. J Dermatol Sci 2012 0.79
23 Effective inhibition of melanosome transfer to keratinocytes by lectins and niacinamide is reversible. Exp Dermatol 2005 0.79
24 Preferential secretion of inducible HSP70 by vitiligo melanocytes under stress. Pigment Cell Melanoma Res 2014 0.79
25 Stem cell factor-KIT signalling plays a pivotal role in regulating pigmentation in mammalian hair. J Pathol 2009 0.79
26 Uveal melanocytes do not respond to or express receptors for alpha-melanocyte-stimulating hormone. Invest Ophthalmol Vis Sci 2006 0.79
27 Interaction between stem cell factor and endothelin-1: effects on melanogenesis in human skin xenografts. Lab Invest 2006 0.78
28 Hydrolytic enzymes of the interfollicular epidermis differ in expression and correlate with the phenotypic difference observed between light and dark skin. J Dermatol 2012 0.77
29 DeoxyArbutin and its derivatives inhibit tyrosinase activity and melanin synthesis without inducing reactive oxygen species or apoptosis. J Drugs Dermatol 2012 0.77
30 Epidermal keratinocytes from light vs. dark skin exhibit differential degradation of melanosomes. J Invest Dermatol 2011 0.76
31 Noninvasive skin measurements after CO(2) and erbium laser resurfacing. Aesthet Surg J 2009 0.75
32 Impaired PIASy-Tip60 signaling weakens activation of p53 in melanoma. Melanoma Res 2013 0.75